18 studies found for:    "glucose-6-phosphate dehydrogenase deficiency"
Show Display Options
Download search resultsDownload the search results for:
"glucose-6-phosphate dehydrogenase deficiency" (18 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Pharmacokinetic and in Vitro Transmission Blocking Activities Study of Primaquine Compare to Methylene Blue in Healthy Volunteer Both G6PD Normal and G6PD Deficiency
Conditions: G6PD Normal;   G6PD Deficient;   Healthy
Intervention: Drug: Regimens (Primaquine, Methylene blue)
2 Enrolling by invitation Comparing G6PD Tests Using Capillary Blood Versus Venous Blood
Condition: Glucose-6 Phosphate Dehydrogenase Deficiency
Intervention: Other: G6PD Test
3 Not yet recruiting Evaluation of Different G6PD Testing Platforms
Condition: Glucose-6-Phosphate Dehydrogenase Deficiency
Intervention:
4 Completed A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency
Conditions: Glucosephosphate Dehydrogenase Deficiency;   Favism
Intervention: Drug: Primaquine
5 Completed Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
Conditions: Glucosephosphate Dehydrogenase Deficiency;   Hyperbilirubinemia;   Hemolytic Disease of Newborn
Intervention: Drug: tin mesoporphyrin
6 Completed G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine)
Condition: Malaria
Interventions: Drug: Chloroquine;   Drug: Primaquine;   Drug: Tafenoquine
7 Completed Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency
Condition: Acne Vulgaris
Interventions: Drug: ACZONE Gel, 5%;   Drug: Vehicle
8 Active, not recruiting Erythrocyte and Adipocyte G6PD Activity Levels in Obesity
Conditions: Diabetes;   Obesity
Intervention:
9 Not yet recruiting Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)
Condition: Malaria
Interventions: Drug: Artemether-Lumefantrine (AL) + 0.25 mg/kg primaquine;   Drug: Artemether-Lumefantrine (AL) combination;   Drug: Artemether-Lumefantrine (AL) + 0.4 mg/kg primaquine
10 Completed Examination of Protective Factors Against Severe Malaria
Conditions: Malaria;   Severe Malaria
Intervention:
11 Completed Collection of Blood From Persons With Hemoglobin and Erythrocyte Polymorphisms for Laboratory Malaria Research
Conditions: Hemoglobin Mutations;   Erythrocyte Variants
Intervention:
12 Recruiting Primaquine Pharmacokinetics in Lactating Women and Their Infants
Condition: Vivax Malaria
Intervention: Drug: Primaquine
13 Completed Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia
Conditions: Hyperbilirubinemia;   Jaundice
Intervention: Procedure: Gene mutation sample
14 Recruiting Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination With Phototherapy in Neonates With Hyperbilirubinemia
Conditions: Jaundice, Neonatal;   Hyperbilirubinemia, Neonatal
Interventions: Drug: stannsoporfin;   Drug: Placebo
15 Completed Malaria Studies in Cambodia
Condition: Malaria
Intervention:
16 Completed Innate and Acquired Resistance to Plasmodium Falciparum Malaria in Mali
Condition: Malaria
Intervention:
17 Completed Lapdap and Coartemether for Uncomplicated Malaria
Condition: Malaria
Interventions: Drug: Chlorproguanil-dapsone (Lapdap);   Drug: Lumefantrine-artemether (Coartemether )
18 Not yet recruiting Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria
Condition: Malaria, Vivax
Interventions: Drug: Tafenoquine;   Drug: Tafenoquine Placebo;   Drug: Chloroquine;   Drug: Primaquine;   Drug: Primaquine Placebo

Indicates status has not been verified in more than two years